These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28367942)

  • 1. Application of low-vacuum scanning electron microscopy in cytopathology: To what extent can adenocarcinoma be morphologically distinguished from squamous cell carcinoma in lung cancer?
    Yano T; Soejima Y; Nakajima Y; Akashi T; Sawabe M
    J Med Dent Sci; 2017; 64(1):1-8. PubMed ID: 28367942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of low vacuum scanning electron microscopy for Papanicolaou-stained slides for cytopathology examinations.
    Yano T; Soejima Y; Sawabe M
    Microscopy (Oxf); 2016 Jun; 65(3):269-73. PubMed ID: 26957591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low vacuum scanning electron microscopy for paraffin sections utilizing the differential stainability of cells and tissues with platinum blue.
    Inaga S; Hirashima S; Tanaka K; Katsumoto T; Kameie T; Nakane H; Naguro T
    Arch Histol Cytol; 2009 Jul; 72(2):101-6. PubMed ID: 20009346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid three-dimensional analysis of renal biopsy sections by low vacuum scanning electron microscopy.
    Inaga S; Kato M; Hirashima S; Munemura C; Okada S; Kameie T; Katsumoto T; Nakane H; Tanaka K; Hayashi K; Naguro T
    Arch Histol Cytol; 2010; 73(3):113-25. PubMed ID: 22572179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological computed tomography features of surgically resectable pulmonary squamous cell carcinomas: impact on prognosis and comparison with adenocarcinomas.
    Koenigkam Santos M; Muley T; Warth A; de Paula WD; Lederlin M; Schnabel PA; Schlemmer HP; Kauczor HU; Heussel CP; Puderbach M
    Eur J Radiol; 2014 Jul; 83(7):1275-1281. PubMed ID: 24840477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
    Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
    Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution CT findings of primary lung cancer with cavitation: a comparison between adenocarcinoma and squamous cell carcinoma.
    Kunihiro Y; Kobayashi T; Tanaka N; Matsumoto T; Okada M; Kamiya M; Ueda K; Kawano H; Matsunaga N
    Clin Radiol; 2016 Nov; 71(11):1126-31. PubMed ID: 27394062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time Trends in Epidemiologic Characteristics and Imaging Features of Lung Adenocarcinoma: A Population Study of 21,113 Cases in China.
    Zhang L; Li M; Wu N; Chen Y
    PLoS One; 2015; 10(8):e0136727. PubMed ID: 26317971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?
    Vincenten JP; Smit EF; Grünberg K; Postmus PE; Snijders PJ; Witte BI; Heideman DA; Thunnissen E
    Lung Cancer; 2015 Jul; 89(1):19-26. PubMed ID: 25982011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of large cell neuroendocrine carcinoma: a population-based overview.
    Derks JL; Hendriks LE; Buikhuisen WA; Groen HJ; Thunnissen E; van Suylen RJ; Houben R; Damhuis RA; Speel EJ; Dingemans AM
    Eur Respir J; 2016 Feb; 47(2):615-24. PubMed ID: 26541538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
    Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klotho expression in cervical cancer: differential expression in adenocarcinoma and squamous cell carcinoma.
    Aviel-Ronen S; Rubinek T; Zadok O; Vituri A; Avivi C; Wolf I; Barshack I
    J Clin Pathol; 2016 Jan; 69(1):53-7. PubMed ID: 26209729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
    Shimizu K; Maeda A; Yukawa T; Nojima Y; Saisho S; Okita R; Nakata M
    World J Surg Oncol; 2014 Nov; 12():343. PubMed ID: 25392182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study.
    Thunnissen E; Noguchi M; Aisner S; Beasley MB; Brambilla E; Chirieac LR; Chung JH; Dacic S; Geisinger KR; Hirsch FR; Ishikawa Y; Kerr KM; Lantejoul S; Matsuno Y; Minami Y; Moreira AL; Pelosi G; Petersen I; Roggli V; Travis WD; Wistuba I; Yatabe Y; Dziadziuszko R; Witte B; Tsao MS; Nicholson AG
    J Thorac Oncol; 2014 Sep; 9(9):1354-62. PubMed ID: 25122431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
    Uke M; Rekhi B; Ajit D; Jambhekar NA
    Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR metabolomics of human lung tumours reveals distinct metabolic signatures for adenocarcinoma and squamous cell carcinoma.
    Rocha CM; Barros AS; Goodfellow BJ; Carreira IM; Gomes A; Sousa V; Bernardo J; Carvalho L; Gil AM; Duarte IF
    Carcinogenesis; 2015 Jan; 36(1):68-75. PubMed ID: 25368033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
    Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
    Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.